P110α and P110δ catalytic subunits of PI3 kinase regulate lysophosphatidylcholine-induced TRPC6 externalization

Area of Science:

• Cell Biology
• Molecular Biology
• Cardiovascular Research

Background:

• Lipid oxidation products like lysophosphatidylcholine (lysoPC) inhibit endothelial cell (EC) migration and arterial healing.
• This inhibition is partly mediated by phosphatidylinositol 3-kinase (PI3K) activation, leading to TRPC6 channel externalization and increased intracellular calcium.

Purpose of the Study:

• To identify specific p110 catalytic subunit isoforms of PI3K responsible for lysoPC-induced TRPC6 externalization.
• To find a targeted intervention for EC migration while minimizing off-target effects on other signaling pathways.

Main Methods:

• Small interfering RNA (siRNA) was used to down-regulate specific p110 isoforms (p110α, p110β, p110δ, p110γ) in endothelial cells.
• Measurements included phosphatidylinositol (3,4,5)-trisphosphate production, TRPC6 channel externalization, and EC migration in the presence of lysoPC.

Main Results:

• Down-regulation of p110α and p110δ isoforms significantly reduced phosphatidylinositol (3,4,5)-trisphosphate production and TRPC6 externalization.
• Targeting p110α and p110δ significantly improved EC migration in the presence of lysoPC.
• p110β and p110γ isoforms were not found to be responsible for lysoPC-induced effects.

Conclusions:

• p110α and p110δ isoforms play specific roles in lysoPC-induced endothelial cell dysfunction.
• These findings identify p110α and p110δ as potential therapeutic targets for improving arterial healing.
• This research provides a basis for future in vivo studies on PI3K isoform inhibition in arterial injury models.